Facetten
Zugriff
Einrichtung
Medientyp
- Text 8
Karte
Erscheinungsjahr
Autor/in
- Mai, Elias K
- Bertsch, Uta 7
- Munder, Markus 6
- Scheid, Christof 5
- Weisel, Katja C 5
- alle zeigen
Sprache
- Englisch 8
8 Einträge gefunden
-
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
- Mai, Elias K
- Huhn, Stefanie
- Miah, Kaya
- Poos, Alexandra M
- Scheid, Christof
- Weisel, Katja C
- Bertsch, Uta
-
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
- Goldschmidt, Hartmut
- Mai, Elias K
- Bertsch, Uta
- Fenk, Roland
- Nievergall, Eva
- Tichy, Diana
- Besemer, Britta
-
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
- Baertsch, Marc-Andrea
- Mai, Elias K
- Hielscher, Thomas
- Bertsch, Uta
- Salwender, Hans J
- Munder, Markus
- Fuhrmann, Stephan
-
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
- Klein, Eva-Maria
- Tichy, Diana
- Salwender, Hans J
- Mai, Elias K
- Duerig, Jan
- Weisel, Katja C
- Benner, Axel
-
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
- Salwender, Hans
- Elmaagacli, Ahmet
- Merz, Maximilian
- Miah, Kaya
- Benner, Axel
- Haenel, Mathias
- Jehn, Christian
-
-